Skip to content
Search AI Powered

Latest Stories

High Times Tumultuous IPO Shelved Yet Again

The Dean of Cannabis Businesses Just Can't Seem to Get Their IPO Act Together
The Dean of Cannabis Businesses Just Can't Seem to Get Their IPO Act Together
Courtesy of The Bluntness Studios

Cannabis Law Report has confirmed that The Securities and Exchange Commission has informed High Times Holdings that they must halt accepting IPO investments because they failed to meet an extended deadline to file their audited annual report.  But, even with this warning, High Times has not refrained from pitching potential Cannabis investors via email solicitations, according to marketing material forwarded to Cannabis Law Report this week.

High Times securities lawyers, Stephen Weiss and Megan Penick of L.A. based Michelman Robinson LLP, who should have been aware of the Company's continued solicitations, confirmed that the High Times will not accept further sales until they get their annual report filed and publicly available for investors.


As of the date of this report, the High Times Investor solicitation portal is still active and functional.

Broken Promises: High Times Troubling IPO Path

The company has extended the offering of shares for two years, initially telling investors that it would list its shares on the NASDAQ. Then it lowered those expectations to the Over-The-Counter Marketplace. Still, neither of these promises has been fulfilled.

According to Debra Borchardt at Green Market Report, High Times continually announces acquisitions, enthusiastically telling investors how much money the new acquisition will bring in. Then months later, the deal typically quietly goes away - sometimes announced in an SEC filing and sometimes through a press release. In some cases, the acquisitions just never close and stay in a suspended state waiting for the shares to go public as payment for the acquisition.

A purchase of working cannabis dispensary stores and licenses in three U.S. states from publicly traded Harvest Health is the most recent example.  The original deal signed in April valued at $80 million included 13 dispensary licenses and then last month it was announced High Times would only be buying 10 licenses and they’d be losing two working California dispensaries in the renegotiated deal.

How Did High Times Become the Fyre Festival of Cannabis?

In 2017, the old-school pot magazine you remember as High Times looked to be blooming into a marijuana empire. That year, The New York Times initially reported that a group of wealthy Los Angeles-based investors, including Bob Marley’s son, Damian, acquired the magazine for $70 million, establishing a new parent company called High Times Holding Co.

However, the Times quickly issued a correction to that report, clarifying that “the group acquired a controlling stake that valued the magazine at $70 million; it did not pay $70 million.” All of this confusion should have been an omen of things to come.

High Times Once Earned 70% of Company Revenue from its Cannabis Cup EventsHigh Times Once Earned 70% of Company Revenue from its Cannabis Cup Events

High Times pivoted its core business to producing Cannabis Cup events, and they went on a spending spree to acquire and put their name on many of the world’s biggest marijuana festivals. These events once accounted for 70% of the Company's revenue, but High Times has not hosted an event since the 2019 Detroit Cannabis Cup.

Closer to home, just one year after acquiring Humboldt County’s popular Reggae on the River music festival, the event was cancelled — and some of their other California Cannabis Cup events failed to get permits or were cancelled last-minute.

High Times carried on with a grand plan for an IPO, hoping to list their shares on the NASDAQ and ride the green rush to riches. But the company couldn’t secure much interest from the traditional investor community, so instead they turned to a much smaller, cannabis-specific penny stock exchange called the OTCQX, and started a crowdfunding campaign aimed at their longtime readers and fans to launch a new mini-IPO. The have yet to raise the level of investment they have been seeking.

In May of 2020, their recently appointed CEO Stormy Simon resigned just after less than 4 months on the job. The company is now on its third CEO in less than a year, a dubious sign for investors and the dispensaries involved, considering this supposedly $80 million transaction is an almost all-stock deal. 

Their stock offering is particularly surreal, because High Times stock technically does not even exist. High Times sends potential investors three or four emails every day with messages like “Time is ticking, don’t miss out!”. The company has now extended its investor deadline at least seven times in the last 18 months.

All we can say is: Buyer Beware.

More For You

Introduction to Psychoactive Mushrooms: The Aztec God Strain - The Bluntness

Introduction to Psychoactive Mushrooms: The Aztec God Strain - The Bluntness

Exploring the Sacred Aztec God Mushroom Strain

Introduction to Psychoactive Mushrooms

Psychoactive mushrooms, also known as hallucinogenic mushrooms, have been revered for centuries across various cultures for their profound spiritual, medicinal, and recreational properties. These remarkable fungi contain psychoactive compounds such as psilocybin and psilocin, which have the power to alter perception, thought, and mood. The use of these mushrooms dates back to ancient Mesoamerican cultures, where they were considered sacred and integral to rituals and ceremonies aimed at communicating with the gods and ancestors. The Aztecs, in particular, held these mushrooms in high esteem, often referring to them as “the flesh of the gods” due to their ability to induce mystical and divine experiences.

What are Aztec God Mushroom strains?

This is a strain of psychedelic mushrooms commonly harvested in Central America and Southern Mexico. They possess a moderate to average psilocybin potency and have been widely utilized by the Aztecs for religious purposes. They are widely cultivated or harvested for their above-average psilocybin content, which is suitable for beginners and prolonged trips when taken in large doses.

Keep ReadingShow less
What is Moon Rocks Weed? - The Bluntness
What is Moon Rocks Weed? - The Bluntness
What is Moon Rocks Weed? - The Bluntness

Moon Rock Weed: Out of This World

What is Moon Rock Weed?

Definition and Composition with Hash Oil

Marijuana moon rocks are a unique and highly potent cannabis product that combines multiple forms of cannabis into one extraordinary item. The creation process begins with high-quality cannabis buds, which are then coated in hash oil—a concentrated form of cannabis extract. This sticky, oil-covered bud is subsequently rolled in kief, a collection of resin glands found on cannabis flowers. The result is a product that boasts THC concentrations of 50% or higher, far surpassing the typical 15-30% found in standard cannabis strains. This combination of cannabis buds, hash oil, and kief makes moon rocks an exceptionally strong and sought-after product in the cannabis community.

History and Rise to Fame

The creation of marijuana moon rocks is credited to West Coast rapper Kurupt, who brought this potent product into the limelight in the mid-2010s through his brand, Kurupt’s Moonrock. Since their introduction, moon rocks have garnered a reputation as a premium cannabis product, often likened to the “champagne” of the marijuana world. Marijuana moon rocks stand as a symbol of both the uniqueness and evolution within the cannabis industry, representing not only high potency but also the creativity in cannabis culture. Their rise to fame has been fueled by their powerful effects and unique composition, making them a favorite among cannabis enthusiasts. The combination of celebrity endorsement and the product’s exceptional potency has solidified moon rocks’ status as a top-tier choice for those seeking an elevated cannabis experience.

Keep ReadingShow less
What Does Weed Do to Your Brain: Effects on Function and Cognition - The Bluntness
What Does Weed Do to Your Brain: Effects on Function and Cognition - The Bluntness
Photo by Anshita Nair on Unsplash

Weed & Your Brain: Function & Cognition

Cannabis, commonly known as weed, affects the brain in several ways. Understanding what does weed do to your brain involves looking at both short-term and long-term effects on cognition and brain function. This article explores these impacts, discussing how different cannabinoids interact with brain receptors and what the consequences might be for frequent users, adolescents, and those with specific health conditions. By the end, you’ll have a clearer picture of how cannabis could influence your cognitive abilities and overall brain health.

Understanding Cannabis and the Brain

An illustration of the human brain highlighting areas affected by cannabis use.


Keep ReadingShow less
FDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness

FDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness

Photo by Wesley Tingey on Unsplash

Landmark PTSD Cannabis OK

For years, military veterans suffering from post-traumatic stress disorder (PTSD) have sought alternative treatments beyond traditional pharmaceuticals. Now, after years of regulatory hurdles and advocacy, the U.S. Food and Drug Administration (FDA) has approved a groundbreaking Phase 2 clinical trial to study the effects of smoked marijuana on veterans with moderate to severe PTSD. Funded by tax revenue from Michigan's legal cannabis sales, this research represents a monumental step toward validating cannabis as a legitimate treatment option for PTSD.

PTSD affects millions of veterans, with many turning to medical marijuana for relief. Anecdotal evidence from veterans suggests that cannabis can alleviate anxiety, improve sleep, and reduce the emotional intensity of traumatic memories. Yet, despite its inclusion in many state-level medical marijuana programs, rigorous clinical data supporting its efficacy has been sparse.

Keep ReadingShow less
DEA prohibited from randomly searching passengers at airports and other transport hubs - The Bluntness

DEA prohibited from randomly searching passengers at airports and other transport hubs - The Bluntness

Photo by Jusdevoyage on Unsplash

No More DEA Traveler Searches!

Republished from NORML with permission.

Agents affiliated with the US Drug Enforcement Administration (DEA) have been instructed to stop searching travelers at airports or other “mass transportation facilities” without a warrant, following a directive issued by Justice Department’s Office of the Inspector General. The directive, issued earlier this month, followed an investigation by the IG’s office. That investigation determined that DEA personnel lacked adequate training and often failed to properly document their search-related activities.

“The DEA’s failure to collect data for each consensual encounter, as required by its own policy, and its continued inability to provide us with any assessment of the success of these interdiction efforts once again raise questions about whether these transportation interdiction activities are an effective use of law enforcement resources – and leaves the DEA once again unable to provide adequate answers to those questions,” Inspector General Michael E. Horowitz determined.

Keep ReadingShow less